FDA Issues Final Guidance Regarding Dear Health Care Provider (DHCP) Letters

Recommendations are Intended to Improve the Communication of Important New or Updated Safety Information for Prescription Drugs and Biological Products - On January 23, 2014, the Food and Drug Administration (FDA) announced in the Federal Register...
By: King & Spalding